image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Synergy Healthcare

March 2009

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 429p
After its shock profit warning three months ago Synergy has unveiled no further setbacks in its third quarter update. Sales in Q3 advanced 15% to £67.9m, while in the first nine months of the current year they increased almost 25% to £201m, in line with expectations. Post the Q2 setback Synergy has reassured that group margins (which had been most affected in decontamination services) are still expected to recover by autumn this year. Importantly, Synergy has won new contracts worth an annualised £6.5m in both linen and decontamination services, while it remains on track to open new facilities over the next few months in Ireland, China and North West England.Net borrowings rose slightly from £153m to £167m although thi ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X